INSIGHT. We find ourselves in a time when groundbreaking technologies such as artificial intelligence, next-generation DNA sequencing, and data-driven precision medicine rapidly reshape the healthcare landscape. The market for AI in healthcare is projected to exceed 100 billion dollars by 2028, with an annual growth rate of over 47% compared
INSIGHT. Peptides (short chains of amino acids) have long been used in the development of pharmaceuticals, such as diabetes medicine. In recent years, we’ve seen a dramatic increase in peptide-based pharmaceuticals. In 2022, peptide pharmaceuticals accounted for 5 percent of the global pharmaceutical market, with a market value of USD
INSIGHT. Medical advancements that save or improve the lives of others often start in the lab, initiated and driven by the curiosity and determination of individual researchers or research teams. In Sweden, renowned for its exceptional universities, researchers have extensive opportunities to transition their discoveries from the lab to the market,
INSIGHT. Sweden is renowned for its strong position in life science – a tradition of research and development coupled with a favourable ecosystem that fosters collaboration and innovation to drive progress. With Sciety, you can invest in leading Swedish life science companies that aim to be acquired or listed on
Sciety has quickly become a prominent player within investments in unlisted life science companies in the Nordics. Founded in 2016 by Andreas Lindblom and Malin Lindblom, Sciety was born from the idea of helping investors find good companies in life science—a field that typically requires industry knowledge. Hear from the
INSIGHT. Women’s health issues have traditionally been underfunded and under-researched but in recent years there has been a growing recognition of the importance of women’s health and the potential for market growth. The White House and the First Lady of the United States, Dr. Jill Biden, recently announced an allocation